::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

EVIDENCE-BASED CLINICAL PRACTICE GUIDELINES FOR LIVER CIRRHOSIS

AUTHORS:

Dr Ali Imran, Dr Rimsha Sehar, Dr Syeda Gul-e-Najaf

ABSTRACT:

Liver disorders are curable at the early stages of onset of disease. After that it may be life threatening. Liver cirrhosis is a late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions such as hepatitis and chronic alcoholism. Each time liver is injured whether by disease, excessive alcohol consumption or another cause like gastrointestinal bleeding and portal hypertension, hepatorenal syndrome, ascites, Hepatic encephalopathy, liver transplant it tries to repair itself. Anticoagulation therapy is proposed for patients with acute-onset or progressive portal vein thrombosis.